Inflammatory disorders

Drug halts organ damage in inflammatory genetic disorder

A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease ...

Neuroscience

ONO-4641 pill reduced number of MS lesions in Phase II trial

An investigational oral drug called ONO-4641 reduced the number of lesions in people with multiple sclerosis (MS), according to the results of a phase two clinical trial to be presented as Emerging Science (formerly known ...

Neuroscience

Can blood pressure drugs reduce the risk of dementia?

People taking the blood pressure drugs called beta blockers may be less likely to have changes in the brain that can be signs of Alzheimer's disease and other types of dementia, according to a study released today that will ...

Neuroscience

Does being a bookworm boost your brainpower in old age?

New research suggests that reading books, writing and participating in brain-stimulating activities at any age may preserve memory. The study is published in the July 3, 2013, online issue of Neurology, the medical journal ...

Neuroscience

Smoldering spots in the brain may signal severe MS

Aided by a high-powered brain scanner and a 3-D printer, NIH researchers peered inside the brains of hundreds of multiple sclerosis patients and found that dark rimmed spots representing ongoing, "smoldering" inflammation, ...

page 6 from 14